PRESTIGE CONSUMER HEALTHCARE (PBH) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:PBH - US74112D1019 - Common Stock
PBH Key Statistics, Chart & Performance
The current stock price of PBH is 59.69 USD. In the past month the price decreased by -1.47%. In the past year, price decreased by -29.22%.
PBH Latest News, Press Relases and Analysis
PBH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 47.57 | 988.98B | ||
| JNJ | JOHNSON & JOHNSON | 19.79 | 494.92B | ||
| MRK | MERCK & CO. INC. | 11.47 | 250.76B | ||
| PFE | PFIZER INC | 7.86 | 143.00B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.36 | 98.22B | ||
| ZTS | ZOETIS INC | 19.63 | 54.84B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.62 | 22.82B | ||
| VTRS | VIATRIS INC | 4.6 | 12.34B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.43 | 11.17B | ||
| CORT | CORCEPT THERAPEUTICS INC | 91.77 | 8.50B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.16B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.26B |
Related stock screener links
About PBH
Company Profile
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 600 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Company Info
PRESTIGE CONSUMER HEALTHCARE
660 White Plains Rd.
Tarrytown NEW YORK 10591 US
CEO: Ronald M. Lombardi
Employees: 570
Phone: 19145246800
PRESTIGE CONSUMER HEALTHCARE / PBH FAQ
What does PRESTIGE CONSUMER HEALTHCARE do?
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 600 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
What is the current price of PBH stock?
The current stock price of PBH is 59.69 USD. The price decreased by -0.4% in the last trading session.
Does PRESTIGE CONSUMER HEALTHCARE pay dividends?
PBH does not pay a dividend.
What is the ChartMill technical and fundamental rating of PBH stock?
PBH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Would investing in PRESTIGE CONSUMER HEALTHCARE be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PBH.
What is the next earnings date for PBH stock?
PRESTIGE CONSUMER HEALTHCARE (PBH) will report earnings on 2026-02-04, before the market open.
Who owns PRESTIGE CONSUMER HEALTHCARE?
You can find the ownership structure of PRESTIGE CONSUMER HEALTHCARE (PBH) on the Ownership tab.
PBH Technical Analysis
PBH Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to PBH. PBH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
PBH Financial Highlights
Over the last trailing twelve months PBH reported a non-GAAP Earnings per Share(EPS) of 4.56. The EPS increased by 13.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.09% | ||
| ROA | 5.83% | ||
| ROE | 11% | ||
| Debt/Equity | 0.55 |
PBH Forecast & Estimates
10 analysts have analysed PBH and the average price target is 79.05 USD. This implies a price increase of 32.43% is expected in the next year compared to the current price of 59.69.
For the next year, analysts expect an EPS growth of 0.67% and a revenue growth -2.36% for PBH